Opera, Italy

Pier Giuseppe Pelicci

USPTO Granted Patents = 3 


Average Co-Inventor Count = 6.9

ph-index = 2

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 2010-2012

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovations of Pier Giuseppe Pelicci

Introduction

Pier Giuseppe Pelicci is a notable inventor based in Opera, Italy. He has made significant contributions to the field of biochemistry, particularly in the development of histone deacetylase inhibitors. With a total of three patents to his name, Pelicci's work has implications for cancer treatment and other diseases.

Latest Patents

Pelicci's latest patents include a class of histone deacetylase inhibitors that are characterized by a general formula involving various chemical components. These inhibitors are designed to target histone deacetylases, which play a crucial role in the regulation of gene expression. His patents describe new compounds that exhibit antitumor activity and detail the processes for their preparation. The compounds are intended for use in treating diseases associated with the deregulation of histone deacetylase activity, such as tumors, and include relevant pharmaceutical compositions for patient administration.

Career Highlights

Pelicci is currently associated with Dac S.r.l., where he continues to innovate in the field of biochemistry. His research has garnered attention for its potential to impact cancer therapies significantly. His work exemplifies the intersection of scientific research and practical application in medicine.

Collaborations

Some of Pelicci's notable coworkers include Antonello Mai and Saverio Minucci. Their collaborative efforts contribute to the advancement of research in histone deacetylase inhibitors and related fields.

Conclusion

Pier Giuseppe Pelicci's contributions to the field of biochemistry through his patents on histone deacetylase inhibitors highlight his role as an influential inventor. His work not only advances scientific knowledge but also holds promise for improving treatment options for patients with cancer and other diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…